Exosomes from Cancer Cells Could Predict Immunotherapy Responses
Immune-Evasion Mechanism May Help Explain the Differences in Responses to Immunotherapy
What the Top 10 Biopharma CEOs Are Making
Surging Markets Drive Double- and Triple-Digit Percentage Gains for Compensation
Epitope Mapping Orients Immune Interventions
Before Launching an Immune Intervention, Get the Lay of the Land
Commercializing Gene Therapies
Using High-Touch Services to Enhance Patient Outcomes
For full access to this article login to GEN Select now.
Multiplexing Ignites Biomarker Research
New Approaches Speed Up Process but Data Analysis Remains Scourge of Many Scientists
- With a goal of making assays bigger, better, and faster, multiplexing is gaining momentum as it tackles challenges in the research and diagnostics arenas. The latter market is projected to reach $6 billion by 2013, according to Scienion. Cutting-edge approaches in this rapidly expanding field include new technologies for ...
Not registered yet? Please fill out the form below and enjoy complimentary access to this and an exclusive collection of premium content and personalization features as a GEN Select insider. Learn More.
Get GEN Select Access Now
- Do not put any letters or characters here if you are not a spy program.